{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:08:48Z","timestamp":1775002128458,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The First People\u2019s Hospital of Yunnan Province","award":["KHYJ-2025-6-08"],"award-info":[{"award-number":["KHYJ-2025-6-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46061-4","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:59:43Z","timestamp":1774630783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained decline in healthcare-associated infections despite stabilized antimicrobial use: a 10-year study in Southwestern China"],"prefix":"10.1038","volume":"16","author":[{"given":"Luoxi","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"9761","key":"46061_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","volume":"377","author":"B Allegranzi","year":"2011","unstructured":"Allegranzi, B. et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet 377 (9761), 228\u2013241 (2011).","journal-title":"Lancet"},{"key":"46061_CR2","unstructured":"Organization, W. H. Global Report on Infection Prevention and Control (World Health Organization, 2022)."},{"issue":"3","key":"46061_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.idc.2021.04.014","volume":"35","author":"G Maki","year":"2021","unstructured":"Maki, G. & Zervos, M. Health care\u2013acquired infections in low-and middle-income countries and the role of infection prevention and control. Infect. Dis. Clin. N. Am. 35 (3), 827 (2021).","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"46061_CR4","doi-asserted-by":"crossref","unstructured":"Suetens, C. et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro. Surveill, 23, 46 (2018).","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800516"},{"key":"46061_CR5","unstructured":"Organization, W. H. Report on the Burden of Endemic Health Care-Associated Infection Worldwide (World Health Organization, 2011)."},{"key":"46061_CR6","unstructured":"World Health Organization. Global report on infection prevention and control, 2024 (2024)."},{"key":"46061_CR7","unstructured":"Organization, W. H. Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals (World Health Organization, 2018)."},{"issue":"46","key":"46061_CR8","doi-asserted-by":"publisher","first-page":"1800393","DOI":"10.2807\/1560-7917.ES.23.46.1800393","volume":"23","author":"D Plachouras","year":"2018","unstructured":"Plachouras, D. et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Eurosurveillance 23 (46), 1800393 (2018).","journal-title":"Eurosurveillance"},{"key":"46061_CR9","doi-asserted-by":"crossref","unstructured":"Vandael, E. et al. Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017. Antimicrobial Resistance Infect. Control 9, 13 (2020).","DOI":"10.1186\/s13756-019-0663-7"},{"issue":"5","key":"46061_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1757177420921924","volume":"21","author":"CL Gibbons","year":"2020","unstructured":"Gibbons, C. L. et al. Comparing national point prevalence surveys of healthcare-associated infection and antimicrobial prescribing: a methodological approach to adjust for differences in case-mix. J. Infect. Prev. 21 (5), 177\u2013181 (2020).","journal-title":"J. Infect. Prev."},{"key":"46061_CR11","unstructured":"Control, E. C. F. D. P. A. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: European Centre for Disease Prevention and Control (2013)."},{"key":"46061_CR12","unstructured":"China, N. H. C. O. T. P. S. R. O. National Action Plan to Contain Antimicrobial Resistance (2016\u20132020). Beijing: National Health Commission of the People\u2019s Republic of China (2016)."},{"key":"46061_CR13","doi-asserted-by":"crossref","unstructured":"Wang, J. et al. The prevalence of healthcare-associated infections in mainland China: a systematic review and meta-analysis. Infect. Control Hospital Epidemiol. 39, 701\u2013709 (2018).","DOI":"10.1017\/ice.2018.60"},{"issue":"1","key":"46061_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12879-025-11046-7","volume":"25","author":"Y Dong","year":"2025","unstructured":"Dong, Y. & Liu, H. Point-prevalence surveys of hospital-acquired infections in 42 Chinese hospitals in Weifang, China: from 2015 to 2020. BMC Infect. Dis. 25 (1), 658 (2025).","journal-title":"BMC Infect. Dis."},{"key":"46061_CR15","unstructured":"Zeng, C. et al. A national point-prevalence survey of healthcare-associated infections in 5,736 medical institutions in China, 2024. Chin. J. Infect. Control. 24(11), 1572\u20131583 (2024)."},{"issue":"12","key":"46061_CR16","doi-asserted-by":"publisher","first-page":"e82785","DOI":"10.1371\/journal.pone.0082785","volume":"8","author":"C Li","year":"2013","unstructured":"Li, C. et al. Changes in antimicrobial use prevalence in China: results from five point prevalence studies. PloS one. 8 (12), e82785 (2013).","journal-title":"PloS one"},{"key":"46061_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2022.02.005","volume":"123","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. A systematic review and meta-analysis of disease burden of healthcare-associated infections in China: an economic burden perspective from general hospitals. J. Hosp. Infect. 123, 1\u201311 (2022).","journal-title":"J. Hosp. Infect."},{"issue":"5","key":"46061_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/1010539517717366","volume":"29","author":"H Li","year":"2017","unstructured":"Li, H. et al. Estimating the direct medical economic burden of health care-associated infections in Public Tertiary Hospitals in Hubei Province, China. Asia Pac. J. Public. Health. 29 (5), 440\u2013450 (2017).","journal-title":"Asia Pac. J. Public. Health"},{"issue":"1","key":"46061_CR19","first-page":"348","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal, J. L., Cummins, S. & Gasparrini, A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int. J. Epidemiol. 46 (1), 348\u2013355 (2017).","journal-title":"Int. J. Epidemiol."},{"issue":"19","key":"46061_CR20","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1002\/sim.1545","volume":"22","author":"VM Muggeo","year":"2003","unstructured":"Muggeo, V. M. Estimating regression models with unknown break-points. Stat. Med. 22 (19), 3055\u20133071 (2003).","journal-title":"Stat. Med."},{"issue":"5","key":"46061_CR21","first-page":"314","volume":"81","author":"Ministry of Health of the People\u2019s Republic Of C","year":"2001","unstructured":"Ministry of Health of the People\u2019s Republic Of C. Diagnostic criteria for nosocomial infections. Chin. Med. J. 81 (5), 314\u2013320 (2001).","journal-title":"Chin. Med. J."},{"key":"46061_CR22","unstructured":"Ministry of Health of the People\u2019s Republic Of C. Measures for the Clinical Application Management of Antimicrobial Drugs. Order No. 84 of the Ministry of Health. Beijing, China: Ministry of Health of the People\u2019s Republic of China (2012)."},{"key":"46061_CR23","unstructured":"National H, Family Planning Commission of the People\u2019s Republic Of C. Notice on Further Strengthening the Management of Clinical Application of Antimicrobial Drugs. Guowei Ban Yi Fa [2015] No. 42. Beijing, China: National Health and Family Planning Commission of the People\u2019s Republic of China (2015)."},{"key":"46061_CR24","doi-asserted-by":"crossref","unstructured":"Zingg, W. et al. National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017. Euro. Surveill. 24, 32 (2019).","DOI":"10.2807\/1560-7917.ES.2019.24.32.1800603"},{"issue":"1","key":"46061_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jiph.2014.07.001","volume":"8","author":"DS Xie","year":"2015","unstructured":"Xie, D. S. et al. A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals. J. Infect. Public. Health. 8 (1), 55\u201361 (2015).","journal-title":"J. Infect. Public. Health"},{"issue":"2","key":"46061_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhin.2019.10.005","volume":"104","author":"T Hopmans","year":"2020","unstructured":"Hopmans, T. et al. Trends in prevalence of healthcare-associated infections and antimicrobial use in hospitals in the Netherlands: 10 years of national point-prevalence surveys. J. Hosp. Infect. 104 (2), 181\u2013187 (2020).","journal-title":"J. Hosp. Infect."},{"issue":"1","key":"46061_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1017\/ice.2021.362","volume":"43","author":"LM Weiner-Lastinger","year":"2022","unstructured":"Weiner-Lastinger, L. M. et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect. Control Hosp. Epidemiol. 43 (1), 12\u201325 (2022).","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"10","key":"46061_CR28","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/cid\/ciab688","volume":"74","author":"MA Baker","year":"2022","unstructured":"Baker, M. A. et al. The Impact of Coronavirus Disease 2019 (COVID-19) on healthcare-associated infections. Clin. Infect. Dis. 74 (10), 1748\u20131754 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"46061_CR29","doi-asserted-by":"publisher","first-page":"117277","DOI":"10.1016\/j.diagmicrobio.2026.117277","volume":"114","author":"S Asokan","year":"2026","unstructured":"Asokan, S. et al. From pandemic influenza to novel coronaviruses: emerging infectious diseases of the 21st century. Diagn. Microbiol. Infect. Dis. 114 (4), 117277 (2026).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"46061_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antibiotics10010001","volume":"10","author":"M Barchitta","year":"2020","unstructured":"Barchitta, M. et al. Three-year trends of healthcare-associated infections and antibiotic use in acute care hospitals: findings from 2016\u20132018 point prevalence surveys in Sicily, Italy. Antibiotics 10 (1), 1 (2020).","journal-title":"Antibiotics"},{"issue":"10","key":"46061_CR31","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/cid\/ciaa373","volume":"72","author":"SS Magill","year":"2021","unstructured":"Magill, S. S. et al. Antimicrobial use in US hospitals: comparison of results from emerging infections program prevalence surveys, 2015 and 2011. Clin. Infect. Dis. 72 (10), 1784\u20131792 (2021).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"46061_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.7326\/M19-1696","volume":"171","author":"MP Cheng","year":"2019","unstructured":"Cheng, M. P. et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann. Intern. Med. 171 (8), 547\u2013554 (2019).","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"46061_CR33","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47 (11), 1181\u20131247 (2021).","journal-title":"Intensive Care Med."},{"issue":"7","key":"46061_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/jama.2017.8531","volume":"318","author":"DJ Morgan","year":"2017","unstructured":"Morgan, D. J., Malani, P. & Diekema, D. J. Diagnostic Stewardship-Leveraging the laboratory to improve antimicrobial use. Jama 318 (7), 607\u2013608 (2017).","journal-title":"Jama"},{"key":"46061_CR35","doi-asserted-by":"crossref","unstructured":"Gentili, A. et al. A six-year point prevalence survey of healthcare-associated infections in an Italian teaching acute care hospital. Int. J. Environ. Res. Public. Health 17, 21 (2020).","DOI":"10.3390\/ijerph17217724"},{"issue":"Suppl 2","key":"46061_CR36","doi-asserted-by":"publisher","first-page":"S148","DOI":"10.1093\/infdis\/jiz556","volume":"221","author":"Y Xiao","year":"2020","unstructured":"Xiao, Y. et al. Change in antibiotic use in secondary and tertiary hospitals nationwide after a National Antimicrobial Stewardship Campaign was launched in China, 2011\u20132016: an observational study. J. Infect. Dis. 221 (Suppl 2), S148\u2013s155 (2020).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"46061_CR37","doi-asserted-by":"publisher","first-page":"e212007","DOI":"10.1001\/jamanetworkopen.2021.2007","volume":"4","author":"SS Magill","year":"2021","unstructured":"Magill, S. S. et al. Assessment of the appropriateness of antimicrobial use in US hospitals. JAMA Netw. Open. 4 (3), e212007 (2021).","journal-title":"JAMA Netw. Open."},{"issue":"2","key":"46061_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/ice.2023.5","volume":"44","author":"V Fabre","year":"2023","unstructured":"Fabre, V. et al. Principles of diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force. Infect. Control Hosp. Epidemiol. 44 (2), 178\u2013185 (2023).","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"1","key":"46061_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13756-022-01201-z","volume":"12","author":"JDM Verberk","year":"2023","unstructured":"Verberk, J. D. M. et al. Healthcare-associated infections in Dutch hospitals during the COVID-19 pandemic. Antimicrob. Resist. Infect. Control. 12 (1), 2 (2023).","journal-title":"Antimicrob. Resist. Infect. Control"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46061-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46061-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:12:19Z","timestamp":1774998739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46061-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46061-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10913"}}